(Q53181157)

12 May 2018

reason for preferred rank

title

Neuroleptic Drugs in the Management of Behavioral Symptoms of Alzheimer’s Disease (English)

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

26 October 2022

Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

author name string

L. E. Tune

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

C. Steele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

T. Cooper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676507

26 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1676507

26 October 2022

publication date

1 June 1991

1 reference

12 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0193953X18303125?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

https://api.elsevier.com/content/article/PII:S0193953X18303125?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Psychiatric Clinics of North America

26 October 2022

published in

1 reference

12 May 2018

volume

14

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

353-373

1 reference

12 May 2018

The value of chemotherapy in senile mental distrubances. Controlled comparison of chlorpromazine, reserpine-pipradrol, and opium.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Efficacy of antipsychotic medications in behaviorally disturbed dementia patients

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Unnecessary Use of Tranquillizers in Elderly Patients

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Thiothixene in the treatment of diseases of the senium

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Loxapine succinate as a neuroleptic agent: evaluation in two populations of elderly psychiatric patients

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Behavior problems in an urban nursing home

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Evaluation of thioridazine in the aged

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Altercations among institutionalized psychogeriatric patients

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

26 October 2022

“Mini-mental state”

15

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The use of mesoridazine in geriatrics

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The effects that patients have on their families in a community care and a control psychiatric service--a two year follow-up.

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Acetophenazine for hyperactive geriatric patients

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The use of trifluoperazine in geriatric patients with chronic brain syndrome.

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Mellaril in the treatment of the geriatric patient

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

The use of thioridazine (Mellaril) in aged people

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Pimozide in the management of psychotically agitated demented patients

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome

26 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Pharmacologic treatment of agitation associated with dementia

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Prevalence of mental illness in a community nursing home.

26 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

HALOPERIDOL IN THE PSYCHIATRIC DISORDERS OF OLD AGE

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Behavioral disturbance in dementia of the Alzheimer's type.

26 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Clinical evaluation of haloperidol in geriatric patients

26 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study

26 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Psychogeriatric dependency rating scales (PGDRS): a method of assessment for use by nurses

26 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

Behavioral problems among patients in skilled nursing facilities.

26 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/S0193-953X(18)30312-5

26 October 2022

Identifiers

1 reference

12 May 2018